Study suggests sodium bicarbonate cotransporter 2 as promising target for rheumatoid arthritis therapy
Groundbreaking study unveils potential of quercetin-3-O-β-D-glucuronide as a leading candidate for osteoarthritis therapy
NORD-STAR trial reveals obesity linked to reduced treatment efficacy in early rheumatoid arthritis patients
Phase 3 KEEPsAKE 1 trial reveals promising efficacy and safety profile of risankizumab in treating active psoriatic arthritis”
Study shows comparable effectiveness of tofacitinib and adalimumab in treating axial spondylarthritis
Swedish cohort study validates the safety of hydroxychloroquine in rheumatic disease during pregnancy
